South Australian clinical registry for metastatic colorectal cancer

ANZ Journal of Surgery

Volumn 81, Issue 5, 2011, Pages 352-357

  Neo, Eu Ling ^a   Beeke, Carol ^a   Price, Timothy ^b   Maddern, Guy ^c   Karapetis, Chris ^a   Luke, Colin ^d   Roder, David ^e   Padbury, Robert ^a  

^a FLINDERS MEDICAL CENTRE   (Australia)

^b QUEEN ELIZABETH HOSPITAL   (Australia)

^c UNIVERSITY OF ADELAIDE   (Australia)

^d DEPARTMENT OF HEALTH   (Australia)

^e CANCER COUNCIL SOUTH AUSTRALIA   (Australia)

Author keywords

Metastatic colorectal cancer registry

Indexed keywords

ANTINEOPLASTIC AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; AUSTRALIA; COLORECTAL TUMOR; FEMALE; HEALTH CARE QUALITY; HUMAN; MALE; METASTASIS; MIDDLE AGED; MORTALITY; PATHOLOGY; REGISTER; STATISTICS; SURVIVAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; QUALITY ASSURANCE, HEALTH CARE; REGISTRIES; SOUTH AUSTRALIA; SURVIVAL ANALYSIS;

EID: 79955153377     PISSN: 14451433     EISSN: 14452197     Source Type: Journal    
DOI: 10.1111/j.1445-2197.2010.05589.x     Document Type: Article

References (27)

1. South Australian Cancer Registry, Epidemiology Branch. Cancer in South Australia 2006 - with projections to 2009. South Australian Department of Health, October 2008.
2. Yoon SS, Tanabe KK. Surgical treatment and other regional treatments for colorectal cancer liver metastases. Oncologist 1999; 4: 197-208.
3. Australian Cancer Network Colorectal Cancer Guidelines Revision Committee. Guidelines for the Prevention, Early Detection and Management of Colorectal Cancer. The Cancer Council Australia and Australian Cancer Network, Sydney 2005.
4. South Australian Cancer Registry (SACR). National Breast Surgery Audit. Epidemiology of Cancer in South Australia - Incidence and Mortality 1999. Adelaide: Openbook Publishers, 2000.
5. National Health Information Management Group (NHIMG). 2001. South Australia Code of Fair Information Practice, Minimum Guidelines for Health Registries for Statistical and Research Purposes.
6. Health Commission Act 1976 (South Australia). Section 64D. 1976.
7. Australian Safety and Efficacy Register of New Interventional Procedures - Surgical. 2000 Annual Report. Adelaide: ASERNIP-S, 2001.
8. Bengmark S, Hafstrom L. The natural history of primary and secondary malignant tumours of the liver. Cancer 1969; 23: 198-202.
9. Price T, Pittman K, Patterson W etal. Management and survival trends in advanced colorectal cancer. Clin. Oncol. 2008; 20: 626-30.
10. Barton M, Gabriel GS, Miles S. Colorectal cancer patterns of care in the Western Sydney and Wentworth Area Health Services. ANZ J. Surg. 2004; 74: 406-12.
11. Sauer R, Becker H, Hohenberger W etal. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N. Engl. J. Med. 2004; 351: 1731-40.
12. Rees M, Tekkis PP, Welsh FKS, O'Rourke T, John TG. Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients. Ann. Surg. 2008; 247: 125-35.
13. Vandeweyer D, Neo EL, Chen JWC, Maddern GJ, Wilson TG, Padbury RTA. Influence of resection margin on survival in hepatic resections for colorectal liver metastases. HPB 2009; 11: 499-504.
14. Fernandez-Trigo V, Shamsa F, Sugarbaker PH. Repeated liver resections from colorectal metastases. Repeat Hepatic Metastases Registry. Surgery 1995; 117: 296-304.
15. Fong Y, Blumgart LH, Cohen A. Repeat hepatic resections for metastatic colorectal cancer. Ann. Surg. 1994; 220: 657-62.
16. Griffith KD, Sugarbaker PH, Chang AE. Repeat hepatic resections for colorectal metastases. Surgery 1990; 107: 101-4.
17. Adam R, Bismuth H, Castaing D etal. Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N. Engl. J. Med. 1997; 225: 51-60.
18. Wanebo HJ, Chu QD, Avradopoulos KA etal. Current perspectives on repeat hepatic resection for colorectal carcinoma: a review. Surgery 1996; 119: 361-71.
19. Khayat D, Gil-Delgado M, Antoine EC etal. The role of irinotecan and oxaliplatin in the treatment of advanced colorectal cancer. Oncology (Huntington) 2001; 15: 415-29.
20. Metanalysis Group in Cancer. Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer. J. Clin. Oncol. 1998; 16: 301-8.
21. Leonard GD, Brenner B, Kemeny NE. Neoadjuvant chemotherapy before liver resection for patients with unresectable liver metastases from colorectal carcinoma. J. Clin. Oncol. 2005; 23: 2038-48.
22. McGrane S, McSweeney SE, Maher MM. Which patients will benefit from percutaneous radiofrequency ablation of colorectal liver metastases? Critically appraised topic. Abdom. Imaging 2008; 33: 48-53.
23. Lim L, Gibbs P, Yip D etal. Prospective study of treatment with selective internal radiation therapy spheres in patients with unresectable or secondary hepatic malignancies. Intern. Med. J. 2005; 35: 222-7.
24. Gray B, Van Hazel G, Hope M, Burton M, Moroz P, Anderson J. Randomised trial of SIR-spheres plus chemotherapy versus chemotherapy alone for treating patients with liver metastases from primary bowel cancer. Ann. Oncol. 2001; 12: 1771-20.
25. Gray BN, Anderson JE, Burton MA, Van Hazel G, Codde J, Morgan C. Regression of liver metastases following treatment with yttrium90 microspheres. ANZ J. Surg. 1992; 62: 105-10.
26. McLoughlin J, Jensen E, Malafa M. Resection of colorectal liver metastases: current perspectives. Cancer Control 2006; 13: 32-41.
27. Fong Y, Fortner J, Sun R, Brennan M, Blumgart L. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann. Surg. 1999; 230: 309-18.